VRAX

Conviction 4HealthcareScan · Thu, Jun 25, 2026

Bullish harami

VRAX$0.1367+3.56%

ResistanceSupportVol 14

Vol MA14 1.55M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Virax Biolabs Group LtdIn Vitro & In Vivo Diagnostic Substanceswww.viraxbiolabs.com ↗

Price0.1367

Change+3.56%

Gap+2.65%

Rel volume0.08×

Avg volume3.62M

Avg $ vol751.26K

SMA 200.1823

SMA 500.1762

SMA 2000.3378

Price vs 50-22.41%

Price vs 200-59.53%

MA stackbearish

50/200 cross—

Supertrenddown · 0.2166

RSI (14)39

MACD hist-0.01

MACD cross—

Stoch %K / %D16 / 9

ADX (14)29

+DI / −DI22 / 21

RSI divergence—

MACD divergence—

ATR %+22.68%

ADR %12.18%

52w high1.11

52w low0.1041

From 52w high-87.68%

Above 52w low+31.32%

New 52w highNo

SqueezeOff

Bollinger width58.20%

%B0.07

Donchian pos12.45%

Donchian high0.2401

Donchian low0.1220

AVWAP (52w high)0.3223

vs AVWAP high-57.59%

AVWAP (52w low)0.2701

vs AVWAP low-49.39%

OBV trendUp

Chaikin MF (20)0.45

Today vs 20d0.08×

Avg vol (14d)1.55M

Avg vol (20d)3.62M

Avg $ vol (20d)751.26K

Market cap593.55K

RS 3m (vs SPY)-37.97%

RS 6m (vs SPY)-73.87%

RS line new highNo

Trend template1/8

Technical rank4.5

1 week-19.11%

1 month-39.78%

3 months-26.11%

6 months-64.49%

1 year-82.94%

YTD-64.40%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value593.55K

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryIn Vitro & In Vivo Diagnostic Substances

ExchangeNasdaq

Shares out4.34M

Employees19

ListedThu, Jul 21, 2022

Free float7.02M

Float %94.5%

Short interest1.07M

Days to cover0.0d

Short volume51.3%

Squeeze score38 / 100

Next earningsWed, Jul 1, 2026 (6d)

EPS forecast−$0.07 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank4.5 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Congress activity

Disclosed STOCK Act trades in VRAX

All disclosures →

No recent disclosed trades by Congress in VRAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRAX

No recent insider (Form 4) filings in VRAX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VRAX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.